207 related articles for article (PubMed ID: 28040393)
1. Synthesis and biological evaluation of naphthoquinone-coumarin conjugates as topoisomerase II inhibitors.
Hueso-Falcón I; Amesty Á; Anaissi-Afonso L; Lorenzo-Castrillejo I; Machín F; Estévez-Braun A
Bioorg Med Chem Lett; 2017 Feb; 27(3):484-489. PubMed ID: 28040393
[TBL] [Abstract][Full Text] [Related]
2. Biophysical and molecular docking studies of naphthoquinone derivatives on the ATPase domain of human topoisomerase II.
Boonyalai N; Sittikul P; Pradidphol N; Kongkathip N
Biomed Pharmacother; 2013 Mar; 67(2):122-8. PubMed ID: 23089478
[TBL] [Abstract][Full Text] [Related]
3. Novel coumarin-pyrazole carboxamide derivatives as potential topoisomerase II inhibitors: Design, synthesis and antibacterial activity.
Liu H; Ren ZL; Wang W; Gong JX; Chu MJ; Ma QW; Wang JC; Lv XH
Eur J Med Chem; 2018 Sep; 157():81-87. PubMed ID: 30075404
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase I/II inhibition by a novel naphthoquinone containing a modified anthracycline ring system.
Kennedy S; DiCesare JC; Sheaff RJ
Biochem Biophys Res Commun; 2011 Apr; 408(1):94-8. PubMed ID: 21458415
[TBL] [Abstract][Full Text] [Related]
5. 1,2-Naphthoquinone as a Poison of Human Type II Topoisomerases.
Collins JA; Osheroff N
Chem Res Toxicol; 2021 Apr; 34(4):1082-1090. PubMed ID: 33760604
[TBL] [Abstract][Full Text] [Related]
6. Design and novel synthetic approach supported with molecular docking and biological evidence for naphthoquinone-hydrazinotriazolothiadiazine analogs as potential anticancer inhibiting topoisomerase-IIB.
Mohamady S; Gibriel AA; Ahmed MS; Hendy MS; Naguib BH
Bioorg Chem; 2020 Mar; 96():103641. PubMed ID: 32032844
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of pharmacologically important naphthoquinones and anticancer activity of 2-benzyllawsone through DNA topoisomerase-II inhibition.
Kumar BS; Ravi K; Verma AK; Fatima K; Hasanain M; Singh A; Sarkar J; Luqman S; Chanda D; Negi AS
Bioorg Med Chem; 2017 Feb; 25(4):1364-1373. PubMed ID: 28094224
[TBL] [Abstract][Full Text] [Related]
8. Tacrine-Coumarin Derivatives as Topoisomerase Inhibitors with Antitumor Effects on A549 Human Lung Carcinoma Cancer Cell Lines.
Konkoľová E; Hudáčová M; Hamuľaková S; Jendželovský R; Vargová J; Ševc J; Fedoročko P; Kožurková M
Molecules; 2021 Feb; 26(4):. PubMed ID: 33672694
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives.
Zhou Y; Xu X; Sun Y; Wang H; Sun H; You Q
Bioorg Med Chem Lett; 2013 May; 23(10):2974-8. PubMed ID: 23566520
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors.
Yao BL; Mai YW; Chen SB; Xie HT; Yao PF; Ou TM; Tan JH; Wang HG; Li D; Huang SL; Gu LQ; Huang ZS
Eur J Med Chem; 2015 Mar; 92():540-53. PubMed ID: 25599951
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of a novel series of pyranonaphthoquinones as topoisomerase II catalytic inhibitors.
Jiménez-Alonso S; Orellana HC; Estévez-Braun A; Ravelo AG; Pérez-Sacau E; Machín F
J Med Chem; 2008 Nov; 51(21):6761-72. PubMed ID: 18816045
[TBL] [Abstract][Full Text] [Related]
12. N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase.
Baviskar AT; Madaan C; Preet R; Mohapatra P; Jain V; Agarwal A; Guchhait SK; Kundu CN; Banerjee UC; Bharatam PV
J Med Chem; 2011 Jul; 54(14):5013-30. PubMed ID: 21644529
[TBL] [Abstract][Full Text] [Related]
13. Pharmacoinformatics analysis of merbarone binding site in human topoisomerase IIα.
Tripathi N; Guchhait SK; Bharatam PV
J Mol Graph Model; 2019 Jan; 86():1-18. PubMed ID: 30296751
[TBL] [Abstract][Full Text] [Related]
14. Design, green one-pot synthesis and molecular docking study of novel N,N-bis(cyanoacetyl)hydrazines and bis-coumarins as effective inhibitors of DNA gyrase and topoisomerase IV.
Metwally NH; Abdallah SO; Mohsen MMA
Bioorg Chem; 2020 Apr; 97():103672. PubMed ID: 32145481
[TBL] [Abstract][Full Text] [Related]
15. Novel anti-tubercular and antibacterial based benzosuberone-thiazole moieties: Synthesis, molecular docking analysis, DNA gyrase supercoiling and ATPase activity.
Omar MA; Masaret GS; Abbas EMH; Abdel-Aziz MM; Harras MF; Farghaly TA
Bioorg Chem; 2020 Nov; 104():104316. PubMed ID: 33022549
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, computational study and biological evaluation of 9-acridinyl and 1-coumarinyl-1,2,3-triazole-4-yl derivatives as topoisomerase II inhibitors.
Abdel-Hafez GA; Mohamed AI; Youssef AF; Simons C; Aboraia AS
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):502-513. PubMed ID: 35012398
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, antitumor activity, and structure-activity relationship study of trihydroxylated 2,4,6-triphenyl pyridines as potent and selective topoisomerase II inhibitors.
Karki R; Park C; Jun KY; Jee JG; Lee JH; Thapa P; Kadayat TM; Kwon Y; Lee ES
Eur J Med Chem; 2014 Sep; 84():555-65. PubMed ID: 25062006
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II.
Zhuo ST; Li CY; Hu MH; Chen SB; Yao PF; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS
Org Biomol Chem; 2013 Jun; 11(24):3989-4005. PubMed ID: 23657605
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human topoisomerases I and II by simocyclinone D8.
Oppegard LM; Nguyen T; Ellis KC; Hiasa H
J Nat Prod; 2012 Aug; 75(8):1485-9. PubMed ID: 22867097
[TBL] [Abstract][Full Text] [Related]
20. Pyrroloquinolinone-based dual topoisomerase I/II inhibitor.
Dalla Via L; Marzaro G; Ferrarese A; Gia O; Chilin A
Eur J Med Chem; 2014 Apr; 77():103-9. PubMed ID: 24631729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
